NCT07128303View on ClinicalTrials.gov

Study of GS-5319 in Adults With Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

178

Participants

Timeline

Start Date

August 28, 2025

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions

Advanced Solid Tumor

Interventions

DRUG

GS-5319

Administered orally

Trial Locations (2)

22031

RECRUITING

NEXT Virginia, Fairfax

78229

RECRUITING

START San Antonio, San Antonio

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY